Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 5/20 | 0.34 |
| ▸ | ESR1 | P03372 | 4/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | METAP2 | P50579 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20207943 | 0.95 | MTOR (0.33) | TOP1ESR1ESR2MAPTMEN1 | |
| SCHEMBL20208138 | 0.93 | MTOR (0.32) | TOP1ESR1ESR2MAPTHSP90AA1 | |
| SCHEMBL21308548 | 0.93 | KDM4E (0.35) | TOP1ESR1ESR2MAPTMEN1 | |
| SCHEMBL21309015 | 0.92 | KDM4E (0.36) | TOP1ESR1ESR2MAPTMEN1 | |
| SCHEMBL20207912 | 0.91 | KDM4E (0.37) | TOP1ESR1ESR2MAPTHSP90AA1 | |
| SCHEMBL20208141 | 0.90 | KDM4E (0.35) | TOP1ESR1ESR2MAPTMEN1 | |
| SCHEMBL21308558 | 0.89 | TOP1 (0.36) | TOP1ESR1ESR2MAPTMEN1 | |
| SCHEMBL20208139 | 0.88 | — | — | |
| SCHEMBL20208142 | 0.88 | PDE10A (0.39) | TOP1ESR1ESR2MAPTMEN1 | |
| SCHEMBL21308554 | 0.88 | PDE10A (0.39) | TOP1ESR1ESR2MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11248008-B2 | Heterocyclic compound and organic light emitting element using same | LT MATERIALS CO., LTD. (KR) | 2022-02-15 | — | — | US | disclosed |
| US-20190263834-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME | HEESUNG MATERIAL LTD. (KR) | 2019-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190263834-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME | CRY1, CRY2, CYP1A1 | TOP1 839/4885ESR1 223/4885ESR2 622/4885 |
| US-11248008-B2 | Heterocyclic compound and organic light emitting element using same | CRY1, CRY2, CYP1A1 | TOP1 839/4885ESR1 223/4885ESR2 622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.